The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant or rescue disitamab vedotin (RC48-ADC) for high-risk non-muscle invasive bladder cancer with HER2 overexpression: A phase II multi-center study.
 
Junru Chen
No Relationships to Disclose
 
Haoyang Liu
No Relationships to Disclose
 
Qiyu Zhu
No Relationships to Disclose
 
Chenhao Xu
No Relationships to Disclose
 
Qiang Wei
No Relationships to Disclose
 
Jiyan Liu
No Relationships to Disclose
 
Zhenhua Liu
No Relationships to Disclose
 
Pengfei Shen
No Relationships to Disclose
 
Yige Bao
No Relationships to Disclose
 
Peng Zhang
No Relationships to Disclose
 
Banghua Liao
No Relationships to Disclose
 
Jin Yao
No Relationships to Disclose
 
Ni Chen
No Relationships to Disclose
 
Kaijie Wu
No Relationships to Disclose
 
Xiaodong Liu
No Relationships to Disclose
 
Hao Zeng
No Relationships to Disclose